Target intelligence / Profile preview

KN motif and ankyrin repeat domain-containing protein 1 (KANK1)

Target
KANK1
Molecular classification
Cytoskeletal adapter protein, Other (adapter protein; not a receptor, channel, enzyme, or transporter)
01

Overview

KN motif and ankyrin repeat domain-containing protein 1 (KANK1) is an adapter protein found in the cytoplasm and nucleus, characterized by coiled-coil and ankyrin repeat domains, and plays a central role in organizing and regulating the actin and microtubule cytoskeletons during cell morphogenesis[1][2][4]. KANK1 negatively regulates cell migration by inhibiting RhoA activation and modulating the binding of signaling molecules such as IRSp53 and 14-3-3, crucial for actin polymerization and formation of cell protrusions[1][2]. It also participates in beta-catenin-dependent transcription when shuttled to the nucleus[1][2][4]. KANK1 acts as a candidate tumor suppressor in renal cell carcinoma and mutations are associated with cerebral palsy spastic quadriplegic type 2 and some myeloproliferative disorders[2][5]. It is not considered a classic therapeutic target such as a receptor or enzyme[2][4].

Other names
KN motif and ankyrin repeat domains 1KANK1ANKRD15KANKKIAA0172ankyrin repeat domain-containing protein 15kidney ankyrin repeat-containing proteinCPSQ2
02

Biological functions

Regulation of actin polymerizationRegulation of microtubule and actin cytoskeleton dynamicsInhibition of cell migrationNegative regulation of RhoA activationBeta-catenin-dependent transcriptionCell morphogenesisCell spreading and migrationAxon guidanceParticipation in wound healing
03

Disease associations

Cancer (candidate tumor suppressor in renal cell carcinoma)Neurodevelopmental disorder (mutations cause cerebral palsy, spastic quadriplegic type 2)Myeloproliferative neoplasm (in rare gene fusions)
04

Safety considerations

Potential impact on cell proliferation and migration, impacting tissue growth and possibly tumor suppression; no reported concerns in therapeutic context
05

Biomarkers

Altered expression as a marker for renal cell carcinoma (not clinically validated)Deletions and mutations associated with cerebral palsy (spastic quadriplegic type 2)

Beyond the preview

Go deeper on KN motif and ankyrin repeat domain-containing protein 1 (KANK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KN motif and ankyrin repeat domain-containing protein 1 (KANK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call